A novel role for the inflammasome in the immunopathogenesis of Candida vaginitis
炎症小体在念珠菌阴道炎免疫发病机制中的新作用
基本信息
- 批准号:9206120
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-15 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAlternative TherapiesAnimalsAntifungal AgentsAspartic EndopeptidasesBacterial AdhesinsBeliefBiologicalBurning PainCASP1 geneCandidaCandida albicansCareer MobilityChronicClinicalConsultCytokine SignalingDataDefectDevelopmentDiseaseEpithelialEpitheliumFacultyFemale of child bearing ageFoundationsFundingFunding OpportunitiesGeneticGenetic TranscriptionGlyburideGoalsHealthHistologicHuman VolunteersImmuneImmune responseImmunityImmunologicsIn VitroInfectionInflammasomeInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInterleukin-1 betaInterleukinsK22 AwardKnockout MiceKnowledgeLactate DehydrogenaseLeadLiquid substanceManuscriptsMeasurementMediatingMediator of activation proteinMedicalMentorsMissionMolecularMorphogenesisMucous MembraneMusNational Institute of Allergy and Infectious DiseaseNeutrophil InfiltrationOralOral mucous membrane structureOutcomeOutputPainPeptide HydrolasesPharmacologyPositioning AttributePredispositionPreventive therapyProcessProductionPruritusPublicationsPublishingQuality of lifeReceptor SignalingRecruitment ActivityRecurrenceRednessResearchResearch PersonnelRoleSeveritiesSignal PathwaySignal TransductionSignaling MoleculeSurfaceSymptomsTestingTissuesTranslational ResearchVaginaVaginal DouchingVaginal ItchingVaginitisVirulenceVirulence FactorsVulvovaginal CandidiasisWomanWorkYeastsadaptive immunitycareercombatcostcytokinedesignexperiencefaculty researchfungusimmunopathologyin vivoinflammatory markerinnovationmembermigrationmouse modelneutrophilnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionoverexpressionpathogenprofessorprogramspublic health relevancereproductiveresponseskillstenure tracktreatment strategy
项目摘要
DESCRIPTION (provided by applicant):
Candida albicans, the primary causative agent of fungal vaginitis, will affect 75% of all women of reproductive age at least once in their lifetime. Static activity of commonly deployed antifungals and chronic infections are of growing concern; therefore, alternative therapies are crucially needed. Despite long-held beliefs that susceptibility to Candida vaginitis resulted from defects in
adaptive immunity, it has recently been shown that the clinical immunopathology (i.e. itching, burning, pain, discomfort, redness of the vaginal mucosa) associated with Candida vaginitis is triggered by robust recruitment of polymorphonuclear leukocytes (PMN) to the vaginal epithelium. Using a mouse model of vaginitis, the S100 alarmins were identified as key signaling molecules in in this hallmark PMN response. However, recent studies using mice deficient in S100 alarmin production still responded with vigorous PMN recruitment when challenged with C. albicans. Therefore, a fundamental gap in knowledge still exists as to the alternative and/or complementary mechanism(s) by which neutrophils are recruited to the vaginal epithelium during Candida vaginitis.
One possible process by which inflammation can be triggered at epithelial surfaces is by activation of the inflammasomes, a group of cytosolic cellular receptors that signal and initiate innate immune responses. Therefore, the objective of this proposal is to 1) demonstrate that the Nlrp3 inflammasome is a key early mediator of the innate inflammatory response and to 2) identify specific hypha-associated C. albicans virulence factors that result in inflammasome activation in the vaginal epithelium. Guided by strong preliminary data, these aims will test our central hypothesis that activation of the inflammasome induced by the C. albicans yeast-to-hypha transition during vaginitis potentiates exacerbated neutrophil influx and pro-inflammatory cytokine signaling in the vaginal epithelium. All aims will utilize a well-established mouse model of vaginitis to test our hypotheses. Under the first aim, genetic or pharmacologic blockade of discrete targets in the inflammasome signaling cascade will be utilized to elucidate signaling pathways contributing to Candida vaginitis. Successful disruption of inflammasome-dependent signaling will be assessed via measurement of inflammatory markers (PMNs, Interleukin-1b, S100 alarmins). In the second aim, morphogenesis-competent C. albicans strains deficient in specific hypha-associated virulence factors (secreted proteinases or adhesins) or strains locked in the yeast form but over-expressing these key identified hyphal virulence factors will be utilized to assess their required role for generating robust innate immune responses in vivo. This approach is innovative because it examines both host and fungal processes required for immune responses associated with Candida vaginitis and seeks to identify inflammasome function in the vaginal mucosa. This proposed work is significant because it will ultimately aid in the identification of novel signaling pathways that may serve as new therapeutic targets for such infections.
This work will also provide a strong foundation on which the candidate can attain an independent academic research program. The candidate's immediate career goal is to successfully transition from a non-tenure track junior faculty member to a tenure-track Assistant Professor position studying the host innate immune response and molecular mechanisms associated with fungal vaginitis. His long-term career goal is to attain a tenured research faculty
position to direct and maintain a well-funded, translational research team that studies innate immune mechanisms to fungal pathogens at the mucosal interface. In order to attain these career goals, aside from conducting the research described above, the candidate will assemble and maintain a supportive mentoring/consulting team that will aid in the successful completion of the research, hone the development of grantsmanship skills leading to effective funding opportunities, and accelerate the publication of high-impact data. Thus, these career goals fulfill
the NIAID's mission to identify novel therapeutic approaches to combat fungal disease and to support junior investigators in making a career transition to independent faculty status under the K22 award mechanism.
描述(由申请人提供):
白色念珠菌是真菌性阴道炎的主要病原体,75% 的育龄妇女一生中至少会感染一次。常用抗真菌药物和慢性感染的静态活性日益受到关注;因此,迫切需要替代疗法。尽管长期以来人们认为对念珠菌性阴道炎的易感性是由以下缺陷引起的:
适应性免疫,最近表明,与念珠菌阴道炎相关的临床免疫病理学(即阴道粘膜瘙痒、灼烧感、疼痛、不适、发红)是由多形核白细胞(PMN)大量招募到阴道上皮所引发的。使用阴道炎小鼠模型,S100 报警素被确定为这一标志性 PMN 反应中的关键信号分子。然而,最近的研究使用 S100 警报素产生缺陷的小鼠,当受到白色念珠菌的攻击时,仍然会出现剧烈的 PMN 募集反应。因此,关于念珠菌阴道炎期间中性粒细胞被募集到阴道上皮的替代和/或补充机制,在知识上仍然存在根本差距。
在上皮表面引发炎症的一个可能过程是通过激活炎症小体,炎症小体是一组发出信号并启动先天免疫反应的胞质细胞受体。因此,该提案的目的是 1) 证明 Nlrp3 炎症小体是先天炎症反应的关键早期介质,2) 识别导致阴道上皮炎症小体激活的特定菌丝相关白色念珠菌毒力因子。在强有力的初步数据的指导下,这些目标将检验我们的中心假设,即阴道炎期间白色念珠菌酵母菌向菌丝转变诱导的炎性小体的激活会加剧阴道上皮中的中性粒细胞流入和促炎细胞因子信号传导。所有目标都将利用成熟的阴道炎小鼠模型来检验我们的假设。在第一个目标下,将利用炎症体信号级联中离散靶点的遗传或药理学阻断来阐明导致念珠菌阴道炎的信号通路。将通过测量炎症标志物(PMN、Interleukin-1b、S100 警报素)来评估是否成功破坏炎症小体依赖性信号传导。在第二个目标中,缺乏特定菌丝相关毒力因子(分泌的蛋白酶或粘附素)的具有形态发生能力的白色念珠菌菌株或锁定在酵母形式但过度表达这些关键已识别菌丝毒力因子的菌株将被用来评估其所需的在体内产生强大的先天免疫反应的作用。这种方法具有创新性,因为它检查了与念珠菌阴道炎相关的免疫反应所需的宿主和真菌过程,并试图识别阴道粘膜中的炎性体功能。这项拟议的工作意义重大,因为它将最终有助于识别新的信号传导途径,这些信号传导途径可以作为此类感染的新治疗靶点。
这项工作还将为候选人获得独立的学术研究项目奠定坚实的基础。该候选人的近期职业目标是成功从非终身教授职位的初级教员过渡到终身职位助理教授职位,研究宿主先天免疫反应和与真菌性阴道炎相关的分子机制。他的长期职业目标是获得终身研究教职
领导和维持一个资金充足的转化研究团队,研究粘膜界面真菌病原体的先天免疫机制。为了实现这些职业目标,除了进行上述研究之外,候选人还将组建并维持一个支持性的指导/咨询团队,这将有助于成功完成研究,磨练资助技能的发展,从而获得有效的资助机会,并加快高影响力数据的发布。因此,这些职业目标实现了
NIAID 的使命是寻找新的治疗方法来对抗真菌病,并支持初级研究人员在 K22 奖励机制下实现职业转型,成为独立教职人员。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa.
念珠菌溶酶驱动阴道粘膜的上皮信号传导、中性粒细胞募集和免疫病理学。
- DOI:
- 发表时间:2018
- 期刊:
- 影响因子:3.1
- 作者:Richardson, Jonathan P;Willems, Hubertine M E;Moyes, David L;Shoaie, Saeed;Barker, Katherine S;Tan, Shir Lynn;Palmer, Glen E;Hube, Bernhard;Naglik, Julian R;Peters, Brian M
- 通讯作者:Peters, Brian M
Polymicrobial Biofilm Studies: From Basic Science to Biofilm Control.
多种微生物生物膜研究:从基础科学到生物膜控制。
- DOI:
- 发表时间:2016-03
- 期刊:
- 影响因子:0
- 作者:Willems, Hubertine Me;Xu, Zhenbo;Peters, Brian M
- 通讯作者:Peters, Brian M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian M Peters其他文献
A fungal metabolic regulator underlies infectious synergism during Candida albicans-Staphylococcus aureus intra-abdominal co-infection
真菌代谢调节剂是白色念珠菌-金黄色葡萄球菌腹内联合感染期间感染协同作用的基础
- DOI:
10.1101/2024.02.15.580531 - 发表时间:
2024-02-15 - 期刊:
- 影响因子:0
- 作者:
Saikat Paul;Olivia A. Todd;Kara R Eichelberger;Christine Tkaczyk;Bret R Sellman;Mairi C. Noverr;J. Cassat;P. Fidel;Brian M Peters - 通讯作者:
Brian M Peters
The atypical antipsychotic aripiprazole alters the outcome of disseminated Candida albicans infections
非典型抗精神病药阿立哌唑改变播散性白色念珠菌感染的结果
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Parker Reitler;Jessica Regan;Christian DeJarnette;Ashish Srivastava;Jen Carnahan;Katie M. Tucker;B. Meibohm;Brian M Peters;Glen E. Palmer - 通讯作者:
Glen E. Palmer
Brian M Peters的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian M Peters', 18)}}的其他基金
Lipid emulsion composition as a determinant of fungal biofilm formation and incidence of candidemia
脂质乳液组合物作为真菌生物膜形成和念珠菌血症发病率的决定因素
- 批准号:
10388392 - 财政年份:2021
- 资助金额:
$ 10.8万 - 项目类别:
Lipid emulsion composition as a determinant of fungal biofilm formation and incidence of candidemia
脂质乳液组合物作为真菌生物膜形成和念珠菌血症发病率的决定因素
- 批准号:
10213517 - 财政年份:2021
- 资助金额:
$ 10.8万 - 项目类别:
Candidalysin: a key mediator of Candida vaginitis immunopathology
念珠菌溶素:念珠菌阴道炎免疫病理学的关键介质
- 批准号:
10229531 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
Candidalysin: a key mediator of Candida vaginitis immunopathology
念珠菌溶素:念珠菌阴道炎免疫病理学的关键介质
- 批准号:
9594689 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
Candidalysin: a key mediator of Candida vaginitis immunopathology
念珠菌溶素:念珠菌阴道炎免疫病理学的关键介质
- 批准号:
9767658 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
A novel role for the inflammasome in the immunopathogenesis of Candida vaginitis
炎症小体在念珠菌阴道炎免疫发病机制中的新作用
- 批准号:
8820695 - 财政年份:2016
- 资助金额:
$ 10.8万 - 项目类别:
相似国自然基金
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Diagnostic and treatment landscape of pyoderma gangrenosum
坏疽性脓皮病的诊治现状
- 批准号:
10732688 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Understanding the regulation of the intestinal epithelium in Alzheimer’s disease by commensal bacteria and the role it plays in preventing neurocognitive decline
了解共生细菌对阿尔茨海默病肠上皮的调节及其在预防神经认知衰退中的作用
- 批准号:
10680057 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Mechanistic study and therapeutic application of AIBP in AMD
AIBP在AMD中的作用机制研究及治疗应用
- 批准号:
10733843 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Novel risk stratification score for patients presenting with acute Cerebral Venous Sinus Thrombosis
急性脑静脉窦血栓形成患者的新风险分层评分
- 批准号:
10592974 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Novel risk stratification score for patients presenting with acute Cerebral Venous Sinus Thrombosis
急性脑静脉窦血栓形成患者的新风险分层评分
- 批准号:
10592974 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别: